Author(s): Anisha Naik, Celina Nazareth, Sarvada Naik Gaonkar

Email(s): celinanaz@yahoo.com

DOI: 10.5958/0974-360X.2020.00382.0   

Address: Anisha Naik, Celina Nazareth*, Sarvada Naik Gaonkar
Department of Pharmaceutical Chemistry, P.E.S’s Rajaram and Tarabai Bandekar College of Pharmacy, Farmagudi, Goa, India- 403401.
*Corresponding Author

Published In:   Volume - 13,      Issue - 5,     Year - 2020


ABSTRACT:
A simple and reproducible, RP-HPLC cleaning validation method for the simultaneous estimation of Olmesartan and Atorvastatin has been developed. The chromatography was carried out on Phenomenex Synergi polar RP- 80A column (250mm×4.6mm, 4µm) in an isocratic mode utilizing ammonium acetate buffer (pH 6.5): acetonitrile (65:35, v/v) as mobile phase, at a flow rate of 1.5mL/min. Detection was carried out at Isosbestic point of 252nm. Retention times of olmesartan and atorvastatin were 3.847±0.2 min and 8.930±0.2 min, respectively. The method was validated as per ICH guidelines. The method was found to be specific as there was no swab interference. The Beer Lambert’s law was obeyed in the concentration range 0.1-10µg/mL for both olmesartan and atorvastatin with Correlation Coefficient, r2 = 0.9999. The % RSD of six replicates and mean % recovery were found to be within acceptable limits for both the drugs. The LOD was 0.003µg/ml for olmesartan and atorvastatin and the LOQ was 0.1µg/ml for olmesartan and atorvastatin which showed that method was sensitive. The method was robust as observed from insignificant variation of analysis results by adopting minor changes in chromatographic conditions. Stability studies conducted on mixed standard solution kept on bench top and under refrigeration conditions showed that the solution was stable on benchtop for 2 h, while the refrigerated solution was stable up to 24 h.


Cite this article:
Anisha Naik, Celina Nazareth, Sarvada Naik Gaonkar. Cleaning Method Development and Validation for the Simultaneous Estimation of Olmesartan and Atorvastatin by HPLC. Research J. Pharm. and Tech 2020; 13(5):2125-2128. doi: 10.5958/0974-360X.2020.00382.0

Cite(Electronic):
Anisha Naik, Celina Nazareth, Sarvada Naik Gaonkar. Cleaning Method Development and Validation for the Simultaneous Estimation of Olmesartan and Atorvastatin by HPLC. Research J. Pharm. and Tech 2020; 13(5):2125-2128. doi: 10.5958/0974-360X.2020.00382.0   Available on: https://rjptonline.org/AbstractView.aspx?PID=2020-13-5-12


REFERENCES:
1.    Tripathi KD. Essentials of Medical Pharmacology. Jaypee Brothers medical publishers Ltd., New Delhi. 2014.
2.    Ashish A. Gawai, Kishor Charhate, Faisal Shaikh, Amir Khan, Aniruddha Chaubey, K. R. Biyani. RP-HPLC method development and validation for hyperlipidemic agent atorvastatin in pharmaceutical dosage form. Research J. Pharm. and Tech. 2017; 10(6): 1780-1787.
3.    Nandini R. Pai, Seema S. Sawant. Development and validation of RP-HPLC method for estimation of olmesartan medoxomil in tablet dosage form. Research J. Pharm. and Tech. 2013; 6(11): 1279-1284.
4.    Celina Nazareth, Shefali Naik, Anwesha Dourado. Development and validation of a simple and rapid RP-HPLC method for the simultaneous estimation of amlodipine and atorvastatin in tablet dosage form. Research J. Pharm. and Tech. 2019; 12(4):1875-1879.
5.    Selvakumar V, Chan QW. RP- HPLC analytical method development and validation for the determination of olmesartan medoxomil in bulk drug and tablets. Formulation development and analysis.2015;1(1):1–6.
6.    Srinivas A, Pradesh A. Stability indicating forced degradation RP-HPLC method development and validation of olmesartan medoxomil. International Journal of Pharmaceutical sciences and Reaserch.2014;5(7):2848–55.
7.    Ganduri R, Lanka RA, Pamidi S. New RP-HPLC method for the determination of olmesartan medoxomil in tablet dosage form. 2011(January);196-201.
8.    Vijaya M, Prasadbabu K, Prasanna KL, Sowjanya P, Prathap M. A new method development and validation for quantitative estimation of olmesartan medoxomil in pharmaceutical dosage form by UV Spectrophotometry. Scholar Acadamic Journal of Pharmacy. 2014;3(3):317–20.
9.    Surekha ML, Swamy GK, Kumar DV. Development and validation of RP-HPLC Method for the estimation of atorvastatin in bulk and tablet dosage form. Int J Pharma Sci. 2012;2(4):91–3.
10.    Vadlamudi MK, Dhanaraj S, Yarkala S, et. al. Development of stability indicating RP-HPLC method for the determination of related substances in atorvastatin solid dosage form and bulk drugs. Int J Pharm Sci.2015;7(12):184-194.
11.    Krishnan SN, Kumar PS, Kumar VN, Surendernath Y. Method development of atorvastatin by RP-HPLC in its bulk dosage forms. International journal of research in Ayurveda and Pharmacy. 2011;2(5):1604–6.
12.    Gadepalli SG, Sistla R. Stability indicating RP-HPLC method for the simultaneous determination of olmesartan medoxomil and atorvastatin calcium. Int J Pharm. 2015; 5(1):196-201.
13.    Das R, Pal TK, Method development and validation of LCMS/MS for atorvastatin and olmesartan in human plasma to trace drug interaction of formulation. Current Pharmaceutical Analysis.2015; 11: 43-52.
14.    Nassani BM. Cleaning Validation in the Pharmaceutical Industry. Inst Valid Technol. 2004;38–58.
15.    http://www.ivtnetwork.com/sites/default/files/Cleaning Validation in the Pharmaceutical Industry_0.pdf [Assessed on 02/09/2017]
16.    Bonneure A, Buggy T, Clingan P, Grootaert A, et al. Guidance on aspects of Cleaning Validation in Active Pharmaceutical Ingredient Plants. 2014, 6–53.
17.    Kalelkar S, Postlewaite J. Sampling for Cleaning Validation — Analytical Considerations. Cleaning and Cleaning Validation.DHI publishing, LLC River Groove, USA, 2013.
18.    ICH. Guidance for industry, Q2B Validation of Analytical Procedures. http://www.ich.org/fileadmin/ Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__ Guideline.pdf (25 October 2018).

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available